"According to the latest report published by Data Bridge Market Research, the Molecular Point of Care Testing (using NAAT) Market
CAGR Value
As per Data Bridge Market Research Analysis the global molecular point of care testing (using NAAT) market size was valued at USD 37.93 billion in 2024 and is expected to reach USD 86.17 billion by 2032, at a CAGR of 1.08%...
The Global Nucleotide Market is expanding as demand increases across pharmaceuticals, biotechnology, food and beverages, animal nutrition, and molecular biology applications. Nucleotides are essential biological molecules that form the building blocks of DNA and RNA. They also play important roles in cellular energy transfer, metabolism, and genetic information storage. Their growing use in...
The Global Nucleic Acid Isolation and Purification Market is experiencing steady expansion as molecular biology, genomics, biotechnology, and clinical diagnostics continue to advance. Nucleic acid isolation and purification are essential laboratory processes used to extract DNA and RNA from biological samples while removing contaminants that may interfere with downstream applications. These...
The Global Latex Medical Gloves Market is experiencing steady growth, supported by rising healthcare expenditure, increasing awareness of infection prevention, and the continued need for protective equipment across medical facilities. Latex medical gloves are widely used by healthcare professionals because of their flexibility, elasticity, tactile sensitivity, and comfortable fit. They provide...
The global In Situ Hybridization (ISH) Market is witnessing significant growth as demand for advanced molecular diagnostic techniques increases across healthcare and life sciences. In Situ Hybridization (ISH) is an important molecular technology used to detect and identify specific nucleic acid sequences within cells and tissue samples. Its ability to provide information about gene expression,...
The global epigenetics market is experiencing significant growth as advancements in genomic research, increasing cancer prevalence, and the expanding adoption of personalized medicine create new opportunities across healthcare and biotechnology industries. The epigenetics market size is projected to reach US$ 35.84 billion by 2031 from US$ 11.12 billion in 2024. The market is expected to...
The Global Longevity Market was valued at US$ 6.23 billion in 2025 and is expected to reach US$ 19.25 billion by 2034. The market is estimated to record a compound annual growth rate of 13.35% during 2026–2034. Increasing interest in healthy aging, rising investments in biotechnology research, and advancements in regenerative medicine are creating significant opportunities for companies...
The Global Tuberculosis Detection Market Size is expected to reach US$5.98 billion by 2034 from US$2.59 billion in 2025. The market is estimated to record a compound annual growth rate of 9.75% from 2026 to 2034. The increasing global burden of tuberculosis, growing demand for early diagnosis, and advancements in molecular diagnostic technologies are supporting the expansion of the market.
The...
The Global NGS Sample Preparation Market is expected to reach US$ 6,059 million by 2031. The market is anticipated to register a CAGR of 12.3% during 2025–2031. Increasing adoption of next-generation sequencing (NGS) technologies, growing demand for precision medicine, rising genomic research activities, and advancements in molecular diagnostics are driving market expansion. NGS sample...
The Global Specialty Pharmaceuticals Market size is projected to reach US$ 2,334.45 billion by 2034 from US$ 293.84 billion in 2025. The market is anticipated to register a CAGR of 25.90% during the forecast period 2026–2034. The growing prevalence of chronic and rare diseases, increasing demand for advanced biologic therapies, rising investments in pharmaceutical research and...
The Aesthetic Injectable Market was valued at US$ 11.07 Billion in 2025 and is projected to reach US$ 19.69 Billion by 2033, registering a CAGR of 7.46% during 2026–2033. This master version evaluates how verified market growth may translate into strategic and commercial value.
What is driving the market?
Growth is supported by rising care demand, chronic-disease management, earlier...
Prostate cancer remains one of the most commonly diagnosed cancers among men worldwide, creating a significant demand for accurate and timely diagnostic solutions. Early detection plays a crucial role in improving treatment outcomes and survival rates, prompting healthcare providers to adopt advanced diagnostic technologies. Growing awareness regarding cancer screening, increasing healthcare...